New Key Statistics Module, Z-Score and F-Score
NAS:RVMD Key Ratios
Market Cap $ M | 6,429.51 |
Enterprise Value $ M | 4,883.30 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 3.76 |
Price/Sales | 960.73 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 4.00 |
EPS (TTM) $ | -3.82 |
Beneish M-Score | -6.68 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -33.20 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -9.66 |
EV-to-EBITDA | -9.85 |
PEG | -- |
Shares Outstanding M | 164.99 |
Net Margin (%) | -10,606.05 |
Operating Margin % | -12,108.78 |
Pre-tax Margin (%) | -10,683.22 |
Quick Ratio | 18.45 |
Current Ratio | 18.45 |
ROA % (ttm) | -34.10 |
ROE % (ttm) | -38.60 |
ROIC % (ttm) | -296.72 |
Dividend Yield % | -- |
Altman Z-Score | 20.59 |
RVMD Number of Guru Trades
RVMD Volume of Guru Trades
Gurus Latest Trades with NAS:RVMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:RVMD is held by these investors
Total 2
Revolution Medicines Inc Insider Transactions
No Available Data
News about NAS:RVMD
Total 0- 1